Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $38.59 USD
Change Today +0.92 / 2.44%
Volume 9.2M
BAX On Other Exchanges
New York
SIX Swiss Ex
As of 4:15 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert M. Davis J.D.

AgeTotal Calculated CompensationThis person is connected to 1 board members in 1 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Robert M. Davis, also known as Rob, J.D., served as the Chief Financial Officer and Executive Vice President at Merck & Co. Inc. since April 23, 2014. Mr. Davis was an Advisor at HealthQuest Capital. Mr. Davis served as Corporate Vice President at Baxter International Inc. from May 17, 2006 to March 27, 2014 and also served as its President at Medical Products from October 2010 to March 27, 2014. Mr. Davis served as the President at Renal at Baxter International ...

Read Full Background

Corporate Headquarters*

One Baxter Parkway
Deerfield, Illinois 60015

United States

Phone: 224-948-2000
Fax: --

Board Members Memberships*



Bachelor's Degree
Miami University
Northwestern University School of Law
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$3,150,384

Stock Options*

Restricted Stock Awards$7,294,765
All Other Compensation$306,213
Unexercisable Options192,572
Total Number of Options192,572

Total Compensation*

Total Annual Cash Compensation$4,268,847
Total Short Term Compensation$3,150,384
Other Long Term Compensation$7,600,978
Total Calculated Compensation$12,762,518
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAX:US $38.59 USD +0.92


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAXTER INTERNATIONAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at